Probiotic products for pet applications

• US 20060008511A1
• Filed: 07/07/2005
• Published: 01/12/2006
• Est. Priority Date: 07/08/2004
• Status: Abandoned Application

• Current Assignee: Imagilin Technologies, LLC
• Original Assignee: Imagilin Technologies, LLC
• Inventors: Lin, Jhy-Jhu, Lin, Jolinta Y.
• Application Number:
  US11/177,264
• Publication Number:
  US 20060008511A1
• Time in Patent Office: Days
• US Class Current: 424/442
• CPC Class Codes: A61K 35/742 Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
• CPC Class Codes: A61K 35/744 Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
• CPC Class Codes: A61K 35/745 Bifidobacteria
• CPC Class Codes: A61K 35/747 Lactobacilli, e.g. L. acidophilus or L. brevis
• CPC Class Codes: A61K 36/06 Fungi, e.g. yeasts
• CPC Class Codes: C12N 11/10 the carrier being a carbohydrate

Abstract

An exemplary embodiment providing one or more improvements includes feeding pets with probiotic microbes encapsulated in a mixture of xanthan gum and chitosan, or in gelatin, specifically Pediococcus acidilactici and Saccharomyces boulardii. Such encapsulation protects the viability of the probiotic microbes against unfavorable temperatures. Such feeding has the benefit of reducing odors, and improving digestion in pets which have these problems.

Claims

1. A preparation for pets comprising viable probiotic microbes encapsulated in a mixture of biopolymers.

2. The preparation of claim 1 wherein the probiotic microbes comprise lactic acid bacteria or yeast.

3. The preparation of claim 2 wherein the probiotic microbes comprise Pediococcus, Lactobacillus, Bifidobacterium, Bacillus, Streptococcus or Enterococcus bacteria or Saccharomyces yeast.

4. The preparation of claim 3 wherein the Pediococcus bacteria is Pediococcus acidilactici and the Saccharomyces yeast is Saccharomyces cerevisiae boulardii.

5. The preparation of claim 1 wherein the biopolymers are xanthan and/or chitosan gum.

6. The preparation of claim 5 wherein the xanthan gum concentration is from about 0.2 percent weight by volume to about 2 percent weight by volume and the concentration of chitosan gum is about 0.1 percent weight by volume to 1.0 percent weight by volume and the pH is from about 2 to about 7.

7. The preparation of claim 6 wherein the xanthan gum concentration is from about 01.25 percent weight by volume and the concentration of chitosan gum is about 0.4 percent weight by volume and the pH is about 4.15.

8. The process of improving the digestion of pets in need of such an improvement comprising the step:

feeding the pet viable encapsulated probiotic microbes.

9. The process of claim 8 wherein the probiotic microbes comprise yeast.

10. The process of claim 8 wherein the probiotic microbes comprise lactic acid bacteria.

11. The process of claim 8 wherein the probiotic microbes comprise yeast and lactic acid bacteria.

12. The process of claim 9 wherein the yeast are Saccharomyces yeast.

13. The process of claim 10 wherein the lactic acid bacteria are Pediococcus, Lactobacillus, Bifidobacterium, Bacillus, Streptococcus or Enterococcus bacteria.

14. The process of claim 11 wherein the probiotic microbes comprise Saccharomyces yeast and one or more lactic bacteria from Pediococcus, Lactobacillus, Bifidobacterium, Bacillus, Streptococcus or Enterococcus bacteria.

15. The process of claim 12 wherein the Saccharomyces yeast is Saccharomyces cerevisiae boulardii.

16. The process of claim 13 wherein the Pediococcus bacteria is Pediococcus acidilactici.

17. The process of claim 14 wherein the probiotic microbes are Saccharomyces cerevisiae boulardii and Pediococcus acidilactici.

18. The process of claim 8 wherein the probiotic microbes are encapsulated in a mixture of xanthan gum and chitosan or in gelatin.

19. The process of claim 8 wherein the pet is a dog, a cat, a rabbit, a guinea pig, a hamster, or a bird.

20. The process of claim 8 wherein the improvement in digestion is increased appetite, reduced diarrhea, increased firmness of stool, reduction in vomiting, reduction of body odor, reduction of flatulence, or improved swallowing.

21. The process of selecting lactic acid bacteria with enhanced immune responses comprising the steps:

cultivating bacteria in low pH and high salt media,

feeding chickens the bacteria,

isolating lactic acid bacteria from the chicken feces,

cultivating the isolated lactic acid bacteria with human cell lines, and

isolating lactic acid bacteria which adhere to the human cell lines.

22. The process of claim 21 wherein the lactic acid bacteria are Pediococcus, Bifidobacterium, Bacillus, Streptococcus or Enterococcus bacteria.

23. The process of claim 22 wherein the Pediococcus bacteria is Pediococcus acidilactici.